Treatment of Parkinson's Disease
AssigneesProthena Biosciences Limited, Hoffmann-La Roche Inc.
InventorGennaro Pagano
Life of this patent
Estimating the term…
Abstract
The invention provides a method of treating, preventing or ameliorating Parkinson's disease with Prasinezumab; wherein providing the patient with a mobile device programmed to receive and transmit data acquired to measure passive and/or active movement of the patient (b) collecting data transmitted from the mobile device; and (c) comparing the data acquired from the patient with control data to assess presence or extent of movement deficits in the subject and/or monitoring the data acquired from the patient for a period of time sufficient to identify changes in the patient's active or passive motor function.
Claims22
A method for monitoring the motor function of a patient that has Parkinson's Disease (PD) or is at risk for PD who has been administered Prasinezumab, the method comprising.
- (a) providing the patient with a mobile device programmed to receive and transmit data acquired from sensors internal and/or external to the mobile device that measure passive and/or active movement of the patient or a mobile device application programmed to receive and transmit data acquired from sensors internal and/or external to the mobile device that measure passive and/or active movement of the patient;
- (b) collecting data transmitted from the mobile device;
- and
- (c) comparing the data acquired from the patient with control data to assess presence or extent of movement deficits in the subject and/or monitoring the data acquired from the patient for a period of time sufficient to identify changes in the patient's active or passive motor function.
Dependencies are inferred from the claim text.